United States pharmaceutical company Pfizer on Tuesday asked regulators to authorise its Covid pill after it was shown to cut hospitalisation or death by nearly 90% among newly infected high-risk patients. The move comes a few weeks after Merck also approached the Food and Drug Administration seeking a green light for its antiviral capsule against the coronavirus.from World News Headlines, Latest International News, World Breaking News - Times of India https://ift.tt/30toL13
Comments
Post a Comment